The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Cheremukhina Yu.V.

N.A. Semashko Regional Clinical Hospital

Borovkova N.Yu.

Privolzhsky Research Medical University

Vasilkova A.S.

Privolzhsky Research Medical University

Vlasova T.V.

Privolzhsky Research Medical University

Akhmedzhanov N.M.

National Medical Research Centre for Therapy and Preventive Medicine

Non-alcoholic fatty liver disease: a view formation on the problem and its significance for the clinical practice

Authors:

Cheremukhina Yu.V., Borovkova N.Yu., Vasilkova A.S., Vlasova T.V., Akhmedzhanov N.M.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2025;28(7): 127‑132

DOI: 10.17116/profmed202528071127

Read: 1565 times

Buy for 300₽
Contact the author
Table of contents

NON-ALCOHOLIC FATTY LIVER DISEASE: A VIEW FORMATION ON THE PROBLEM AND ITS SIGNIFICANCE FOR THE CLINICAL PRACTICE
NON-ALCOHOLIC FATTY LIVER DISEASE: A VIEW FORMATION ON THE PROBLEM AND ITS SIGNIFICANCE FOR THE CLINICAL PRACTICE

To cite this article:

Cheremukhina YuV, Borovkova NYu, Vasilkova AS, Vlasova TV, Akhmedzhanov NM. Non-alcoholic fatty liver disease: a view formation on the problem and its significance for the clinical practice. Russian Journal of Preventive Medicine. 2025;28(7):127‑132. (In Russ.)
https://doi.org/10.17116/profmed202528071127

Подписка 2026 Профилактическая медицина (Russian Journal of Preventive Medicine)
МСФ на ЯМ
Использование инфографики авторами научных работ
Recommended articles:
Prevalence of meta­bolic syndrome among the indi­genous popu­lation in central Yaku­tia rural areas. Russian Journal of Preventive Medi­cine. 2025;(5):21-26
Effi­ciency of anthropometric surrogate indi­ces for the meta­bolic syndrome and its components diagnosing in middle-aged Moscow men. Russian Journal of Preventive Medi­cine. 2025;(5):41-48
The condition of bone tissue in patients with non-alcoholic fatty liver disease. Russian Journal of Preventive Medi­cine. 2025;(5):82-89
Retrospective analysis of sexually transmitted infe­ctions inci­dence in countries of the world. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):132-142
Epidemiology of M. geni­talium infe­ction. What is known?. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):143-152
Clinical case of primary hype­raldosteronism dete­cted during pregnancy: differential diagnosis, neonatal prognosis. Russian Bulletin of Obstetrician-Gynecologist. 2025;(2):98-104
Treatment and prevention of suture failure and bleeding after various bariatric inte­rventions. Piro­gov Russian Journal of Surgery. 2025;(5):79-85
Diagnosis of pathological and adaptive bala­nce changes in Parkinson’s disease to select a reha­bilitation program. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):88-94
Cognitive impairment in patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):67-73
Postoperative peri­tonitis: epidemiology, diagnosis, surgical treatment and prognosis. Piro­gov Russian Journal of Surgery. 2025;(6):104-111
Abstract:

The problem of non-alcoholic fatty liver disease (NAFLD) is of great interest to the medical community due to its high prevalence and its proven role in the development and progression of cardiometabolic disorders and cancer.

OBJECTIVE

To analyze data related to epidemiology, developing of views on etiology and modern approaches to diagnosing of non-alcoholic fatty liver disease.

MATERIALS AND METHODS

The PubMed, RSCI, and eLibrary databases were searched for Russian and foreign publications using the keywords non-alcoholic fatty liver disease, obesity, cardiovascular risks, and insulin resistance. The data presented in reviews, articles, meta-analyses, and clinical guidelines were analyzed. Publication selection criteria were relevant articles in peer-reviewed periodicals with epidemiological data and a modern view of the problem of NAFLD with detailed descriptive statistics. The search period included 2014 to 2024. In addition, the review uses sources published earlier than 2000 with relevant data on the study topic.

RESULTS

The problem analysis demonstrated a high prevalence of NAFLD (averaging about 33% in the general population). Studies of non-alcoholic liver injury have been ongoing for a long time. According to modern views, this condition has a complex pathogenesis involving the hepatobiliary system and other organs and systems. New non-invasive diagnostic methods (elastometry, magnetic resonance imaging of the liver) are promising since they can detect the disease early.

CONCLUSION

Non-alcoholic fatty liver disease is well understood. However, more evidence of its role in developing other diseases associated with metabolic dysfunction is being revealed. It is necessary to search for new methods of diagnosing and treating this condition to improve the prognosis and reduce cardiometabolic risk.

Keywords:

non-alcoholic fatty liver disease
metabolic syndrome
epidemiology
etiopathogenesis
diagnosis

Authors:

Cheremukhina Yu.V.

N.A. Semashko Regional Clinical Hospital

Borovkova N.Yu.

Privolzhsky Research Medical University

Vasilkova A.S.

Privolzhsky Research Medical University

Vlasova T.V.

Privolzhsky Research Medical University

Akhmedzhanov N.M.

National Medical Research Centre for Therapy and Preventive Medicine

Received:

31.01.2025

Accepted:

13.05.2025

Close metadata

References:

  1. Maev IV, Andreev DN, Kucheryavyj YuA. Rasprostranennost' nealkogol'noj zhirovoj bolezni pecheni v Rossii: metaanaliz. Consilium Medicum. 2023; 25(5):313-319. (In Russ.). https://doi.org/10.26442/20751753.2023.5.202155
  2. Ivashkin VT, Drapkina OM, Maev IV, et al. Prevalence of non-alcoholic fatty liver disease in out-patients of the Russian Federation: DIREG 2 study results. Rossijskij zhurnal gastrojenterologii, gepatologii, koloproktologii. 2016;25(6):31-41. (In Russ.). https://www.gastro-j.ru/jour/article/view/1036/717
  3. Vinickaya EV, Sandler YuG, Bordin DS. The New Paradigm of Non-Alcoholic Fatty Liver Disease: Phenotypic Diversity of Metabolically Associated Fatty Liver Disease. Effektivnaya farmakoterapiya. 2020;16(24):54-63. (In Russ.). https://doi.org/10.33978/2307-3586-2020-16-24-54-63
  4. Klinicheskie rekomendacii. Nealkogol`naya zhirovaya bolezn` pecheni u vzrosly`x. 2024. Accessed May 25, 2025. (In Russ.). https://rsls.ru/files/KRNGBP2024.pdf
  5. Best CH, Hartroft WS. Liver damage produced by feeding alcohol or sugar and its prevention by choline. British Medical Journal. 1949;2(4635):1002-1006. https://doi.org/10.1136/bmj.2.4635.1001
  6. Hanssen P. Enlargement of the liver in diabetes mellitus. JAMA. 1936;106: 914-916. 
  7. Thaler H. The fatty liver and its pathogenetic relation to liver cirrhosis. Virchows Archiv fur pathologische Anatomie und Physiologie und fur Klinische Medizin. 1962;335:180-210. 
  8. Ludwig J, Viggiano TR, McGill DB, et al. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clinic Proceedings. 1980;55(7):434-438. 
  9. Mayo Clinic Gastroenterology and Hepatology Board Review. Editor-in-chief S.C. Hauser; associate editors A.S. Oxentenko, W. Sanchez. 5th edition. 2015.
  10. Maccalau AJ. New information for non-alcoholic fatty liver disease. Journal of Clinical Gastroenterology. 2002;34:255-262. 
  11. Nonalcoholic steatohepatitis clinical research network. Hepatology. 2003; 37(2):244.  https://doi.org/10.1002/hep.510370203
  12. Lavine JE, Schwimmer JB. Pediatric non-alcoholic steatohepatitis. Non-alcoholic steatohepatitis. Ed. by G. Farrell, J. George, P. Hall, A. McCollough. Oxford, England: Blackwell Publishing; 2004;229-240. 
  13. Krolevec TS, Livzan MA. Non-alcoholic fatty liver disease: digest 2021. Russian Journal of Evidence-Based Gastroenterology. 2021;10(2):27-35. (In Russ.). https://doi.org/10.17116/dokgastro20211002127
  14. Day CP, James OF. Steatohepatitis: a tale of two «hits»? Gastroenterology. 1998;114:842-845.  https://doi.org/10.1016/s0016-5085(98)70599-2
  15. Sharma M, Mitnala S, Vishnubhotla RK, et al. The Riddle of Nonalcoholic Fatty Liver Disease: Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis. Journal of Clinical and Experimental Hepatology. 2015;5(2):147-158.  https://doi.org/10.1016/j.jceh.2015.02.002
  16. Maev IV, Andreev DN, Kucheryavyy YuA, et al. Metabolicheski assotsiirovannaia zhirovaia bolezn’ pecheni. M.: Prima Print; 2021. (In Russ.).
  17. Maev IV, Kucheryavy YuA, Andreev DN. Pechen‘ i biliarnyi trakt pri metabolicheskom syndrome. Posobie dlia vrachei. M., 2020. (In Russ.).
  18. Tsukanov VV, Osipenko MF, Beloborodova EV, et al. Practical aspects of clinical manifestations, pathogenesis and therapy of alcoholic liver disease and non-alcoholic fatty liver disease: Expert opinion. Rossijskij zhurnal gastrojenterologii, gepatologii, koloproktologii. 2023;33(4):7-13. (In Russ.). https://doi.org/10.22416/1382-4376-2023-33-4-7-13
  19. Halilova DM, Sahautdinova GM. About the role of intestinal microbiota in the pathogenesis and treatment of non-alcoholic fatty liver disease. Lechashchij Vrach. 2024;5(27):48-56. (In Russ.). https://doi.org/10.51793/OS.2024.27.5.009
  20. Liu C, Liu T, Zhang Q, et al. New-Onset Age of Nonalcoholic Fatty Liver Disease and Cancer Risk. JAMA Network Open. 2023;6(9):e233551. https://doi.org/10.1001/jamanetworkopen.2023.35511
  21. Maevskaya MV, Kotovskaya YuV, Ivashkin VT, et al. The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities. Terapevticheskii arkhiv. 2022;94(2): 216-253. (In Russ.). https://doi.org/10.26442/00403660.2022.02.201363
  22. Nelidova AV, Livzan MA, Nikolaev NA, et al. Cardiovascular Diseases and Non-Alcoholic Fatty Liver Disease: Relationship and Pathogenetic Aspects of Pharmacotherapy. Racional'naya farmakoterapiya v kardiologii. 2021;17(6): 880-888. (In Russ.). https://doi.org/10.20996/1819-6446-2021-12-14
  23. SHabanin SA, Pchelin IYu. Specific features of metabolic disorders in males and females with non-alcoholic fatty liver disease. Juvenis scientia. 2020; 6(6):18-32. (In Russ.). https://doi.org/10.32415/jscientia_2020_6_6_18-32
  24. Nosov AE, Zenina MT, Gorbushina OYu, et al. Diagnostic significance of clinical and laboratory indices in predicting non-alcoholic fatty liver disease during screening studies. Terapevticheskij arhiv. 2021;93(8):883-889. (In Russ.). https://doi.org/10.26442/00403660.2021.08.200973
  25. Ivashkin VT, Maevskaya MV, Zharkova MS. Clinical Practice Guidelines of the Russian Scientific Liver Society, Russian Gastroenterological Association, Russian Association of Endocrinologists, Russian Association of Gerontologists and Geriatricians and National Society for Preventive Cardiology on Diagnosis and Treatment of Non-Alcoholic Liver Disease. Rossijskij zhurnal gastroenterologii, gepatologii, koloproktologii. 2022;32(4):104-140. (In Russ.). https://doi.org/10.22416/1382-4376-2022-32-4-104-140
  26. Hernaez R, Lazo M, Bonekamp S, et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology. 2011;54(3):1082-1090. https://doi.org/10.1002/hep.24452
  27. Lee DH. Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification. Clinical and Molecular Hepatology. 2017;23(4):290-301.  https://doi.org/10.3350/cmh.2017.0042
  28. Allakhverdieva YaS, Vorob’ev SV, Mineev NI. Modern opportunities of magnetic-resonance technologies in diagnostics of the fatty liver. Medicinskij vestnik Severnogo Kavkaza. 2018;13(4):695-700. (In Russ.). https://doi.org/10.14300/mnnc.2018.13140
  29. Caussy C, Reeder SB, Sirlin CB, et al. Noninvasive, Quantitative Assessment of Liver Fat by MRI-PDFF as an Endpoint in NASH Trials. Hepatology. 2018;68(2):763-772.  https://doi.org/10.1002/hep.29797
  30. Permutt Z, Le TA, Peterson MR, et al. Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease- MRI accurately quantifies hepatic steatosis in NAFLD. Alimentary Pharmacology and Therapeutics. 2012;36:22-29.  https://doi.org/10.1111/j.1365-2036.2012.05121.x
  31. Trang A, Tan J, Sun M. Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology. 2013; 267:422-431.  https://doi.org/10.1148/radiol.12120896
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.